KIAA1614 and COVID-19: However, from Table 4, we see that ABCB6 is positively correlated with KIAA1614 and MND1, and then, an increase in ABCB6 expression level may result in an increase in MND1 expression level and KIAA1614 expression level, which increases the COVID-19 competing risk CF-I.